Comparison cloud for lectures indicating the words that appeared most frequently in each period (2013-2017, top, blue colour; 2018-2023, bottom, red colour). by Ignacio García-Espona (21395335)

Subjects:

Top ten countries in terms of lecturers (left) and posters (right). by Ignacio García-Espona (21395335)

Subjects:

Comparison cloud indicating the words that appeared most frequently with respect to each type of contribution (lectures, top, blue colour; posters, bottom, red colour) [2013-2023]. by Ignacio García-Espona (21395335)

Subjects:

Lectures and posters by country (2013-2023) [Only countries featuring at least 25 contributions] (Abbreviations: US: United States of America, BR: Brazil, MX: Mexico, KR: South Kor... by Ignacio García-Espona (21395335)

Subjects:

Correlogram of the relationships among the variables. by Ignacio García-Espona (21395335)

Subjects:

Efficiency analysis of various countries [left column: countries ordered according to our national global indicator; central column: countries ordered according to the number of le... by Ignacio García-Espona (21395335)

Subjects:

Comparison cloud indicating the words that appeared most frequently with regard to each type of lecturer (lecturers from the USA, top, blue colour; lecturers not from the USA, bott... by Ignacio García-Espona (21395335)

Subjects:

Global number of lectures and posters (2013-2023). by Ignacio García-Espona (21395335)

Subjects:

Comparison cloud for posters indicating the words that appeared most frequently in each period (2013-2017, top, blue colour; 2018-2023, bottom, red colour). by Ignacio García-Espona (21395335)

Subjects:

Poster ratios (women/men) by country and year [Top 10 countries] (Abbreviations: AU: Australia, BR: Brazil, CA: Canada, CN: China, DE: Germany, IT: Italy, JP: Japan, KR: South Kore... by Ignacio García-Espona (21395335)

Subjects:

Lectures by country and year [Top 10 countries] (Abbreviations: AU: Australia, BR: Brazil, CA: Canada, CN: China, DE: Germany, IT: Italy, JP: Japan, KR: South Korea, TW: Taiwan, US... by Ignacio García-Espona (21395335)

Subjects:

Lectures by country and year [Top 2-10 countries] (Abbreviations: AU: Australia, BR: Brazil, CA: Canada, CN: China, DE: Germany, IT: Italy, JP: Japan, KR: South Korea, TW: Taiwan). by Ignacio García-Espona (21395335)

Subjects:

Lecturer ratios (women/men) by country and year [Top 10 countries] (Abbreviations: AU: Australia, BR: Brazil, CA: Canada, CN: China, DE: Germany, IT: Italy, JP: Japan, KR: South Ko... by Ignacio García-Espona (21395335)

Subjects:

Variations in the prevalence of OASI in France between 2010 and 2021 according to the classification for episiotomy practices. by Raphaele Houlbracq (20558509)

Subjects:

Trends in the characteristics of women giving birth vaginally in France between 2010 and 2021. by Raphaele Houlbracq (20558509)

Subjects:

Variations in the prevalence of episiotomy in France between 2010 and 2021 according to the classification for episiotomy practices. by Raphaele Houlbracq (20558509)

Subjects:

Flow chart. by Raphaele Houlbracq (20558509)

Subjects:

pmed.1004501.t001 - Episiotomies and obstetric anal sphincter injuries following a restrictive episiotomy policy in France: An analysis of the 2010, 2016, and 2021 National Perinat... by Raphaele Houlbracq (20558509)

Subjects:

Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

“…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”

Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

“…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”